Towards Healthcare
ADC Outsourcing Service Market to Lead USD 5.19 Bn by 2034

ADC Outsourcing Service Market Gains from CRDMO Demand

Market insights predict, the ADC outsourcing service industry is expected to grow from USD 2.76 billion in 2024 to USD 5.19 billion by 2034, driven by a CAGR of 6.52%. The growing demand for targeted therapeutics and increasing R&D investments bolster market growth. North America dominated the global market owing to the presence of key players and favorable regulatory policies.

Content

  • Last Updated: 20 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The ADC outsourcing service market is valued at USD 2.94 billion in 2025 and is on track to reach USD 5.19 billion by 2034, witnessing a steady CAGR of 6.52% during the forecast span.

North America is leading the ADC outsourcing service market share by 45% due to the availability of state-of-the-art research and development facilities, the presence of key players, and favorable regulatory policies.

Some key players include Lonza, Catalent, AbbVie, and ICON plc.

ADCs can treat certain blood cancers and cancerous tumors during recurrence when other treatments are ineffective.

Food and Drug Administration, Government of Canada, GOV.UK, Press Information Bureau
Any Questions